Welcome to our dedicated page for SmartKem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SmartKem's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SmartKem's regulatory disclosures and financial reporting.
SmartKem, Inc. entered into an additional bridge financing with Ferrox Critical Minerals on July 27, 2026, funding a $4,500,000.00 Convertible Promissory Note. The note bears 5.0% annual interest, matures on January 31, 2027, paid SmartKem a $400,000.00 origination fee, and is convertible into Ferrox ordinary shares based on the lower of fair market value or an $80,000,000 fully diluted equity valuation. On default, interest rises to 15% and a $4,500.00 per day default management fee applies, alongside restrictive covenants and a right of first refusal and exclusivity for defined Fundamental Transactions through December 31, 2026.
SmartKem also continued its private financing under a previously disclosed Series A convertible preferred stock purchase agreement. Additional closings on June 22, July 16 and July 24, 2026 issued 5,000, 1,250 and 2,500 Series A shares, respectively, with accompanying warrants, for cash proceeds of approximately $4.0 million, $1.0 million and $2.0 million. As of July 27, 2026, 25,862,643 shares of SmartKem common stock were issued and outstanding.
AIGH Capital Management LLC, AIGH Investment Partners LLC, and Orin Hirschman report beneficial ownership of SmartKem, Inc. common stock. They collectively report beneficial ownership of 1,095,791 shares, all issuable upon exercise of warrants.
This position represents 4.9% of the class, keeping their reported ownership below the 5% threshold. The warrant position excludes an additional 238,992 common shares issuable upon exercise of warrants that are not currently exercisable because of beneficial ownership limitations. The Reporting Persons have no voting power over these shares but report sole dispositive power over the 1,095,791 warrant shares.
SmartKem, Inc. amended its existing Series A preferred stock financing on July 16, 2026 by entering Amendment No. 1 to its Securities Purchase Agreement with institutional investors. The amendment permits a new party to join as a Buyer and reallocates among Buyers the remaining Series A convertible preferred shares and accompanying warrants available for purchase at future Additional Closings, without changing the aggregate amounts available.
Under the agreement, at the initial March 30, 2026 closing the company issued 11,411.5 shares of Series A convertible preferred stock, each with a stated value of $1,000, and warrants to purchase up to 23,251,960 shares of common stock in a private placement. Buyers also hold rights to require one or more Additional Closings for up to an aggregate of 10,000 additional Series A preferred shares and related warrants.
At a June 22, 2026 Additional Closing, the company sold 5,000 Series A preferred shares and 10,753,615 warrants for aggregate cash proceeds of approximately $4.0 million. At a subsequent Additional Closing on July 16, 2026, it sold 1,250 Series A preferred shares and 2,688,404 warrants for aggregate cash proceeds of approximately $1.0 million. These securities were issued in unregistered private placements relying on exemptions under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D.
SmartKem, Inc. is registering up to 160,260,999 shares of its Common Stock for resale by selling stockholders. The registered shares comprise 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares and 101,910,995 Additional RRA Shares. The Company will not receive proceeds from sales by the selling stockholders; the Company will receive proceeds only if Warrants are exercised for cash. The registration covers shares issuable upon conversion of Series A Preferred Stock and upon exercise of Warrants issued in private placements and an Additional Closing on June 22, 2026. The prospectus notes trading on Nasdaq under the symbol SMTK and discloses a last reported sale price of $0.2364 per share on July 1, 2026. The document also summarizes recent financings, including a senior secured notes financing of $3,750,000 (original principal) and an equity line commitment up to $500,000,000 or 19.99% of outstanding shares (Keystone).
SmartKem, Inc. filed an amendment to a Form S-3 to register 160,260,999 shares of Common Stock for resale by selling stockholders. The registered shares comprise 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares, and 101,910,995 Additional RRA Shares.
The prospectus states the company will not receive proceeds from resales by selling stockholders but will receive net proceeds from any Warrants exercised for cash. The filing also discloses recent financings and transactions, including an Equity Line providing up to $500,000,000 or 19.99% of shares, a $3,750,000 senior secured note issuance, and a $300,000 settlement payment tied to patent assignments. Shares trade on Nasdaq under the symbol SMTK, last reported at $0.2364 on July 1, 2026.
SmartKem, Inc. filed a shelf registration to permit resale of up to 160,260,999 shares of Common Stock by selling stockholders pursuant to private placements and related transactions, including 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares and 101,910,995 Additional RRA Shares. The company will not receive proceeds from these resales but will receive net proceeds if any warrants are exercised for cash.
The filing discloses recent financings and strategic transactions: an equity line of credit commitment up to $500,000,000 or 19.99% of outstanding shares, senior secured notes with an original principal of $3,750,000 (issued at a purchase price of $2,625,000), a $300,000 settlement payment and related patent assignment, and various private placements and conversions completed earlier in 2026.
SmartKem, Inc. entered into a new convertible bridge loan and completed an additional private financing. The company funded Ferrox Critical Minerals with a $2,500,000.00 Convertible Promissory Note bearing 5.0% annual interest and maturing on December 31, 2026, plus a $200,000.00 origination fee, tighter covenants, and broad rights of first refusal and exclusivity on major Ferrox transactions.
Separately, SmartKem closed an Additional Closing under its Series A Preferred Stock Securities Purchase Agreement, issuing 5,000 shares of Series A convertible preferred stock and 10,753,615 warrants for aggregate cash proceeds of approximately $4.0 million in a private placement relying on Regulation D and Section 4(a)(2) exemptions.
SmartKem, Inc. reported the results of its annual stockholder meeting, where all eleven proposals received the required approvals. Stockholders elected two Class II directors to terms through 2029 and gave advisory approval to the executive compensation program and annual say-on-pay frequency.
They ratified CBIZ CPAS P.C. as auditor for the year ending December 31, 2026. Stockholders also approved a major increase in authorized common shares from 300,000,000 to 5,000,000,000, an expansion of the 2021 Equity Incentive Plan share pool, and authority for the board to effect up to two reverse stock splits.
In addition, stockholders approved issuing common stock below the Nasdaq minimum price in excess of 19.99% of outstanding shares in connection with both the company’s Equity Line of Credit and its Series A convertible preferred stock and related warrants. They also adopted amendments allowing stockholder action by written consent and removing certain two-thirds supermajority voting requirements.
SmartKem, Inc. reported that the directors of its wholly owned UK subsidiary, SmartKem, Ltd., have instructed an administrator to begin placing that subsidiary into creditors voluntary liquidation. The company stated that this step will not impact its current operations and that it has not made any filing under any bankruptcy code or statutory reorganization scheme in either the United States or the United Kingdom. SmartKem, Inc. continues to operate its business.